Search

Your search keyword '"Flanagan E"' showing total 463 results

Search Constraints

Start Over You searched for: Author "Flanagan E" Remove constraint Author: "Flanagan E"
463 results on '"Flanagan E"'

Search Results

1. Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

2. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques

5. P1141 Global perspectives on managing Inflammatory Bowel Disease (IBD) during pregnancy and lactation: current state and the necessity for enhancements

6. P644 Body composition does not predict clinical course in patients with acute severe ulcerative colitis

7. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

8. The effectiveness and acceptability of a computerised guided self-help programme for vaginismus : a mixed methods design

9. Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis

11. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifiesLRRC4C, LHX5-AS1and nominates ancestry-specific lociPTPRK,GRB14, andKIAA0825as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium

12. Clinical outcomes amongst elderly patients with inflammatory bowel disease

13. New insights into the genetic etiology of Alzheimer's disease and related dementias

18. Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

21. Longitudinal retinal optical coherence tomography in myelin oligodendrocyte glycoprotein antibody disorders

22. Microfibril-associated protein 4 (MFAP4) as a biomarker for disease activity of optic neuritis associated-inflammatory demyelinating diseases

26. A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.

27. Ustekinumab levels in pregnant women with inflammatory bowel disease and neonates exposed in utero.

31. Anti-tumor necrosis factor-alpha induction therapy for patients with active inflammatory bowel disease during pregnancy is effective and safe.

33. Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates

36. Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

37. Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients with Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis.

38. Abdominal Imaging in pregnancy (maternal and foetal risks).

39. Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

40. Maternal Exposure to Ambient Air Pollution and Risk of Preeclampsia: A Population-Based Cohort Study in Scania, Sweden

41. Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford

49. Automated Insulin Delivery in Women With Pregnancy Complicated by Type 1 Diabetes

Catalog

Books, media, physical & digital resources